Renal insufficiency: Usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment

Radiology

Volumn 210, Issue 3, 1999, Pages 663-672

  Spinosa, David J ^a   Matsumoto, Alan H ^a   Angle, J Fritz ^a   Hagspiel, Klaus D ^a   McGraw, J Kevin ^b   Ayers, Carlos ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b St Vincent Mercy Children's Hospital   (United States)

Author keywords

Angiography, contrast media; Carbon dioxide; Gadolinium; Renal arteries, stenosis or obstruction

Indexed keywords

CARBON DIOXIDE; CONTRAST MEDIUM; GADODIAMIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; INTERVENTIONAL RADIOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032975436     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.3.r99fe58663     Document Type: Article

References (70)

1. Tegtmeyer CJ, Selby JB Jr. Percutaneous transluminal angioplasty of the renal arteries. In: Castaneda-Zuniga WR, ed. Interventional radiology. Baltimore, Md: Williams & Wilkins, 1997; 364-377.
2. Tegtmeyer CJ, Kellum CD, Ayers C. Percutaneous transluminal angioplasty of the renal artery: results of long-term follow-up. Radiology 1984; 153:77-84.
3. Martin LG, Price RB, Casarella WJ, et al. Percutaneous angioplasty in clinical management of renovascular hypertension: initial and long-term results. Radiology 1985; 155:629-633.
4. Colapinto RF, Stronell RD, Harries-Jones EP, et al. Percutaneous transluminal dilatation of the renal artery: follow-up studies on renovascular hypertension. AJR 1982; 139:727-732.
5. Geyskes CG, Puylaert CBAJ, Oei HY, Mees EJ. Follow-up study of 70 patients with renal artery stenosis treated by percutaneous transluminal dilation. Br Med J 1983; 287:333-336.
6. Sos TA, Pickering TG, Field D, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274-279.
7. Madias NE. Renovascular hypertension. AKF Nephrol Lett 1986; 3:27-42.
8. Kaplan NM. Renovascular hypertension. In: Clinical hypertension. 4th ed. Baltimore, Md: Williams & Wilkins, 1986; 317-344.
9. Tegtmeyer CJ, Matsumoto AH, Johnson AM. Renal angioplasty. In: Baum S, Pentecost MJ, eds. Abrams angiography interventional radiology. Boston, Mass: Little, Brown, 1997; 294-325.
10. Dawson DL. Non-invasive assessment of renal artery stenosis. Semin Vasc Surg 1996; 93:172-181.
11. Maxwell MH, Bleifer AK, Franklin SS, Barady PD. Cooperative study of renovascular hypertension: demographic analysis of the study. JAMA 1972; 220:1195-1204.
12. Bude RO, Rubin JM. Detection of renal artery stenosis with Doppler sonography: it is more complicated than originally thought (editorial). Radiology 1995; 196: 612-613.
13. Tublin NU, Dodd GD III. Sonography of renal transplantation. Radiol Clin North Am 1995; 33:447-459.
14. Erley CM, Duda SH, Wakat JP, et al. Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients: a prospective analysis. Transplantation 1992; 54:863-867.
15. Hertz SM, Baum RA, Owen RS, et al. Comparison of magnetic resonance angiography and contrast angiography in peripheral artery stenosis. Am J Surg 1993; 166:1123-1126.
16. Kent CK, Edelman RR, Kim D, et al. Magnetic resonance angiography: a reliable test for evaluation of proximal atherosclerotic renal artery stenosis. J Vasc Surg 1991; 13:311-318.
17. Yucel KE, Kaufman JA, Prince M, et al. Time-of-flight renal MR angiography: utility in patients with renal insufficiency. Magn Reson Imaging 1993; 11:925-930.
18. Duda SH, Shick F, Teufl F, et al. Phase contrast MR angiography for detection of atherosclerotic renal artery stenosis. Acta Radiol 1997; 38:287-291.
19. Hawkins IF. Carbon dioxide digital subtraction angiography. AJR 1982; 139:19-24.
20. Hawkins IF, Maynar M. Carbon dioxide digital subtraction angiography: In: Castaneda-Zuniga WR, ed. Interventional radiology. 3rd ed. Baltimore, Md: Williams & Wilkins, 1997; 429-443.
21. Weaver FA, Pentecost MJ, Yellin AE, et al. Clinical applications of carbon dioxide/ digital subtraction angiography. J Vasc Surg 1991; 13:266-272.
22. Ehrman KO, Tabor TE, Gaylord GNM, et al. Comparison of diagnostic accuracy with carbon dioxide versus iodinated contrast material in imaging of hemodialysis access fistulas. JVIR 1994; 5:771-775.
23. Kinno Y, Odagiri K, Ando K, et al. Gadopentetate dimeglumine as an alternative contrast agent for the use in angiography. AJR 1993; 160:1293-1294.
24. Matchett WJ, McFarland DR, Russell DK, Sailors DM, Moursi MM. Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 1996; 201:569-751.
25. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD. Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty in stent placement. Kidney Int 1998; 53:503-507.
26. Hawkins IF, Caridi JG, Kerns SR. Plastic bag delivery system for hand injection of carbon dioxide. AJR 1995; 165:1487-1489.
27. Qian Z. Vascular stents: Palmaz balloon-expandible stent. In: Castaneda-Zuniga WR, ed. Interventional radiology. 3rd ed. Baltimore, Md: Williams & Wilkins, 1997; 681-697.
28. Tegtmeyer CJ. Percutaneous transluminal angioplasty. Curr Probl Diagn Radiol 1987; 16:75-139.
29. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331:1416-1420.
30. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11:383-392.
31. Tollefeson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991; 14:327-331.
32. Ernst CB, Stanley JC, Marshall FF, et al. Autogenous saphenous vein aortorenal allografts: a 10 year experience. Arch Surg 1972; 105:855-864.
33. Stoney RF, Olofsson PA. Aortorenal arterial allografts: the last two decades. Ann Vasc Surg 1988; 2:169-173.
34. Comire JM, Fichelle JM, Laurian C, et al. Renal artery revascularization with polytetrafluoroethylene bypass graft. Ann Vasc Surg 1990; 4:471-478.
35. Brewster DC, Darling RC. Splenorenal arterial anastomosis for renal vascular hypertension. Ann Surg 1979; 189:353-358.
36. Chibaro EA, Libertino JA, Novick AC. Use of hepatic circulation for renal revascularization. Ann Surg 1984; 199:406-411.
37. Fry RE, Fry WJ. Supra celiac aortorenal bypass with saphenous vein for renovascular hypertension. Surg Gynecol Obstet 1989; 168:181-182.
38. Novick AC, Stewart R. Use of the thoracic aorta for renal revascularization. J Urol 1990; 143:77-79.
39. Novick AC, Ziegelbaum M, Vidt DG, Gifford RW Jr, Pohl MA, Goormastic M. Trends in surgical revascularization for renal artery disease: ten years' experience. JAMA 1987; 257:498-501.
40. Libertino JA, Bosco PJ, Ying CY, et al. Renal revascularization to preserve and restore renal function. J Urol 1992; 147: 1485-1487.
41. Hallett JW, Fowl R, O'Bryan PC, et al. Renovascular operations in patients with chronic renal insufficiency: do the benefits justify the risks? J Vasc Surg 1987; 5:622-627.
42. Hansen KJ, Starr SM, Sands RE, Burkart JM, Plong GW Jr, Dean RH. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16:219-331.
43. Martin LG, Rees CR, O'Bryant T. Percutaneous angioplasty of the renal arteries. In: Strandis DE, vanBrada A, eds. Vascular diseases: surgical and interventional therapy. New York, NY: Churchill Livingstone, 1994; 721-741.
44. Pickering TG, Sos TA, Saddekni S, et al. Renal angioplasty in patients with azotemia and renovascular hypertension (abstr). J Hypertens 1986; 4(suppl 6):S667.
45. Mercier C, Piquet P, Alimi Y, et al. Occlusive disease of the renal arteries and chronic renal failure: the limits of reconstructive surgery. Ann Vasc Surg 1990; 4:166-170.
46. Taylor DC, Kettler MD, Moneta GL, et al. Duplex sonography in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg 1988; 7:363-369.
47. Chen CC, Hoffer PB, Vahjen G, et al. Patients at high risk for renal artery stenosis: a simple method of renal scintigraphic analysis with Tc-99m DTPA and captopril. Radiology 1990; 176:365-370.
48. Stafford-Johnson BD, Lerner CA, Prince MR, et al. Gadolinium-enhanced magnetic resonance angiography of renal transplants. Magn Reson Imaging 1997; 15:13-20.
49. Siegelman ES, Gilfeather M, Holland GA, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the renovascular system. AJR 1997; 168:1035-1040.
50. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204:297-312.
51. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230-242.
52. Mansky CA, Sprafka JM, Storney JP, Wang I. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89:615-620.
53. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41:1274-1279.
54. Picus D, Neely JP, McClennen BL, et al. Intraarterial digital subtraction angiography of renal transplants. AJR 1985; 145:93-96.
55. Weaver FA, Pentecost MJ, Yellen AA, et al. Clinical applications of carbon dioxide/ digital subtraction angiography. J Vasc Surg 1991; 13:266-272.
56. Strunk H, Thelen M, Schild H, Lippok K. Carbon dioxide: contrast medium for digital substraction angiography. Fortschr Med 1993; 111:122-125. [German]
57. 2 digital substraction angiography: potential complications and their prevention. JVIR 1997; 8:383-391.
58. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, Hooper TN. Transient mesenteric ischemia: a complication of carbon dioxide angiography. JVIR 1998; 9:561-564.
59. Rundback JH, Shah PM, Wong J, et al. Livedo reticularis, rhabdomyolysis, massive intestinal infarction, and death after carbon dioxide angiography. J Vasc Surg 1997; 26:337-340.
60. Fobbe F, Wacker M, Wagner S. Arterial angiography in high kilovoltage technique with gadolinium as a contrast agent: first clinical experience. Eur Radiol 1996; 6:224-229.
61. Kaufman JA, Galler SC, Waltman AC. Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 1996; 198:579-581.
62. Schild VHH, Weber W, Boeck E, et al. Gadolinium-DTPA (Magnivist) als kontrastmittel für die arterielle DSA. ROFO 1994; 160:218-221.
63. Spinosa DJ, Hartwell JD, Angle JF, Hagspiel KD, Agarwal SJ, Matsumoto AH. Optimizing imaging technique for gadolinium contrast angiography (abstr). JVIR 1988; 9(suppl 1):192.
64. Reinton V, Pharm KJ, Berg MG, et al. Pharmacokinetics of gadodiamide injections in patients with moderately impaired renal function. Acad Radiol 1994; 1(suppl):S56-S61.
65. Harpur ES, Worah D, Hals PA, et al. Preclinical safety assessment in pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 1993; 28(suppl 1): S28-S42.
66. Niendorf HP, Haustine J, Louten T, Beck W, Laniado M. Safety and tolerance after intravascular administration of 0.3 mmol/kg Gd-DTPA: results of randomized, controlled clinical trial. Invest Radiol 1991; 26(suppl 1):S221-S223.
67. Prince MR, Arnoldus C, Frazoll JK. Nephrotoxicity of high dose gadolinium compared with iodinated contrast material. JMRI 1996; 6:162-166.
68. Arsenault TN, King BF, Morris JW, et al. Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of initial experience. Mayo Clin Proc 1996; 71:1150-1154.
69. Byrd KJ, Lundby B, Renten V, et al. Gadodiamide in renal transplant patients: effective renal function in use as a glomerular filtration rate marker. Nephron 1996; 72: 212-217.
70. Canzanello BJ, Milan VG, Spiegel JE, et al. Percutaneous transluminal renal angioplasty in management of atherosclerotic renal vascular hypertension: results in 100 patients. Hypertension 1989; 13:163-172.